GLP-1 drugs may reduce the risk of cancer progressing, study suggests

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...

Weight-loss drugs from Lilly, Novo linked to stalling cancer: report

New studies link GLP-1 drugs like Ozempic and Mounjaro to lower cancer progression and death risk, including breast cancer ...

AI technology revolutionizes heart scan interpretation with 99% accuracy

AI technology can read heart scans with 99% accuracy and researchers find a new path with drug-resistant tumors. These are ...

GLP-1 Weight Loss Drugs May Reduce the Chance of Certain Cancers Progressing, New Study Suggests

GLP-1 medications were initially developed and prescribed to help manage blood sugar in people with Type 2 diabetes ...

Ozempic and other GLP-1 RAs could slow progression of some cancers, data suggest

Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related ...